Matinas Biopharma Holdings Inc. (MTNB) Dipped -8.16% or -0.08 To Price $0.96 On Tuesday


Matinas Biopharma Holdings Inc. (MTNB) dipped -8.16% or -0.08 to $0.96. It is close to 1.66 million shares traded, which is 111.85% compare to the average total volume 1.48 million. The market cap of MTNB is $90.39 million. The year to date change is -24.29%. The 52 week price range is from $0.32 to $1.6. Price of MTNB have changed 38.89% during last week. It have changed 113.55% over last month, 160.00% over last 3 months, 40.54% over last 6 months and -22.96% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MTNB is 0.45. It is -53.13% below current price. The 200-day Moving Averages for MTNB is 0.73. It is -23.96% below current price. The 52-week High is 1.6. It is 66.67% from the current price. The 52-week Low is 0.32. It is -66.67% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of MTNB is 6.56 on 2018-09-14. Short % to float is 2.04%. There are some statistics of MTNB. It is has market cap $90.39 million. The share outstanding is 94.64 million. The average volume is 1.48 million. The percent of top 15 Institution holding is 7.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MTNB is -315.02%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MTNB is -88.51%.


Tags:

Share this post